CARISMA Therapeutics To Present at Upcoming Virtual Investor Conferences In December
CARISMA Therapeutics Inc., a biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that Steven Kelly, the President & CEO, will present at two virtual investor conferences in December 2020.
- Piper Sandler 32nd Annual Virtual Healthcare Conference
November 30, 2020- December 3, 2020
Presentations will be available for registered attendees via the Piper Sandler conference site from November 23 to December 3.
- 2020 RBC Capital Markets Healthcare Private Company Conference
Tuesday, December 15, 2020 at 9:20am EST
About CARISMA Therapeutics Inc.
CARISMA Therapeutics Inc. is a biopharmaceutical company developing a differentiated and proprietary cell therapy platform focused on engineered macrophages, cells that play a crucial role in both the innate and adaptive immune response. The first applications of the platform, developed in collaboration with the University of Pennsylvania, are autologous chimeric antigen receptor (CAR)-macrophages for the treatment of solid tumors. CARISMA Therapeutics is headquartered in Philadelphia, PA.